Revealing the difference between small molecule drugs and biologics and illustrating why cash and equivalents is the most important line item on biotech balance sheets.

School is in session on Industry Focus as we provide a 101-style overview of important investing topics. First up: return on invested capital with real world examples from Buffalo Wild Wings, Whole Foods Market, and Marriott International.

We run through a Fool U class on how to spot disruptive companies and a few caveats to keep in mind as you look.

This traditionally "Red" state is leading the way with wind power generation, and that has big ramifications for investors.

Americans are spending more money on their pets than ever before and that's good news for people investing in these pet stocks.

McDonald’s and Wal-Mart -- the two biggest names in their respective industries. Steve Easterbrook and Doug McMillon -- the two men who have risen through the ranks over two decades and now hold the reins at each company. Facing major headwinds, we look at these massive businesses and how their CEOs are leading them into the future.

 As school starts up, make sure your money can make the grade.

We talk about one of the toughest decisions an investor faces -- when to sell a stock.

Driverless car technology will be available to any automaker that wants it by 2019 – here’s what investors need to know.

An EpiPen pricing debacle, an unexpected FDA rejection, and a sticker-shock inspiring M&A deal led to wild moves in Mylan N.V., Portola Pharmaceuticals, and Medivation this week.